View from the Nation's Capital. "Off-label" uses of approved drugs: limits on physicians' prescribing behavior.
作者信息
Appler W D, McMann G L
出版信息
J Clin Psychopharmacol. 1989 Oct;9(5):368-70.
PMID:2794099
Abstract
摘要
相似文献
1
View from the Nation's Capital. "Off-label" uses of approved drugs: limits on physicians' prescribing behavior.来自美国首都的视角。已获批药物的“非标签”用途：对医生处方行为的限制。
J Clin Psychopharmacol. 1989 Oct;9(5):368-70.
2
View from the Nation's Courts.
J Clin Psychopharmacol. 1988 Dec;8(6):434-6.
3
View from the Nation's Capital. DEA considers relaxing restrictions on medical use of marijuana.
J Clin Psychopharmacol. 1988 Apr;8(2):133-4.
4
What's happening with pharmaceuticals? And how will it impact your practice?制药行业正在发生什么？它将如何影响你的业务？
Tenn Med. 2005 May;98(5):213-6.
5
Marketing off-label uses to physicians: FDA's draft (mis)guidance.向医生推销药品的未标明用途：美国食品药品监督管理局的（错误）指导草案
Am J Bioeth. 2008 Mar;8(3):1-3. doi: 10.1080/15265160802116624.
6
A physician's prerogative to prescribe drugs for off-label uses during pregnancy.
Obstet Gynecol. 1993 Jun;81(6):1052-5.
7
A new era in drug regulation?药品监管的新时代？
Hastings Cent Rep. 2005 May-Jun;35(3):10-1.
8
Regulating off-label drug use--rethinking the role of the FDA.规范药品的非标签使用——重新审视美国食品药品监督管理局的作用。
N Engl J Med. 2008 Apr 3;358(14):1427-9. doi: 10.1056/NEJMp0802107.
9
View from the Nation's Capital.
J Clin Psychopharmacol. 1983 Aug;3(4):253-5.
10
The growing role of epidemiology in drug safety regulation.流行病学在药物安全监管中日益重要的作用。
Epidemiology. 2011 Sep;22(5):622-4. doi: 10.1097/EDE.0b013e31822837ba.
Zotero 插件